NCT03409120View on ClinicalTrials.gov

Unlocking Dystonia From Parkinson's Disease With Directional DBS Technology

NACompletedINTERVENTIONAL
Enrollment

38

Participants

Timeline

Start Date

January 1, 2018

Primary Completion Date

June 30, 2021

Study Completion Date

June 30, 2022

Conditions
Dystonia-Parkinsonism, Adult-OnsetParkinson Disease
Interventions
DEVICE

Boston Scientific Vercise PC IPG with directional DBS lead

We will contrast the effects of omnidirectional versus directional STN DBS on dystonia symptoms in patients with PD.

Trial Locations (1)

35294

University of Alabama at Birmingham, Birmingham

All Listed Sponsors
collaborator

Michael J. Fox Foundation for Parkinson's Research

OTHER

lead

University of Alabama at Birmingham

OTHER

NCT03409120 - Unlocking Dystonia From Parkinson's Disease With Directional DBS Technology | Biotech Hunter | Biotech Hunter